01 1Taro Pharmaceutical Industries
01 1LAMOTRIGINE USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-04-07
Pay. Date : 2024-04-03
DMF Number : 18960
Submission : 2005-11-17
Status : Active
Type : II
20
Taro Pharmaceutical Industries Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LAMOTRIGINE USP, with a corresponding US DMF Number 18960.
Remarkably, this DMF maintains an Active status since its submission on November 17, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 07, 2024, and payment made on April 03, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
